Active Gastrointestinal and Other Cancers Grants

PI Namesort ascending Organization - Company Title Major Program / Research Group FOA
Wang, Thomas D University Of Michigan At Ann Arbor Early Targets in Progression of Barrett's Esophagus to Esophageal Adenocarcinoma Barrett's Esophagus Translational Research Network PA-20-272: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
Waldman, Scott A Thomas Jefferson University Guanylin GUCY2C axis in Colorectal Cancer Initiation PA-13-302: Research Project Grant
Vilar-Sanchez, Eduardo University Of Tx Md Anderson Can Ctr Cancer Immune-Interception for Lynch Syndrome PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Vilar-Sanchez, Eduardo University Of Tx Md Anderson Can Ctr Cancer Immune-Interception in a Spontaneous Non-Human Primate Model of Lynch Syndrome PA-20-185: NIH Research Project Grant
Vilar-Sanchez, Eduardo University Of Tx Md Anderson Can Ctr Uncovering the Role of Colorectal Stem Cells on Disease Penetrance in Lynch Syndrome RFA-CA-15-008: Research Answers to NCI's Provocative Questions
Ulrich, Cornelia M. University Of Utah Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer link PA-20-185: NIH Research Project Grant
Schmit, Stephanie L Cleveland Clinic Lerner Com-Cwru Variation in tumor-associated immune profiles and colorectal cancer outcomes PAR-18-654: Basic Research in Cancer Health Disparities
Moyer, Matthew T. Pennsylvania State Univ Hershey Med Ctr CHARM 2: Chemotherapy for ablation and resolution of mucinous pancreatic cysts: a prospective, randomized, double-blind, multi-center clinical trial PA-16-160: NIH Research Project Grant
Markowitz, Sanford D. Case Western Reserve University Targeting 15-Prostaglandin Dehydrogenase (15-PGDH) in Cancer Risk, Prevention, and Treatment PAR-15-342: NCI Outstanding Investigator Award
Malafa, Mokenge P H. Lee Moffitt Cancer Ctr & Res Inst Novel Therapy to Inhibit IPMN Progression PAR-21-035: Cancer Prevention and Control Clinical Trials Grant Program
Lipkin, Steven M Weill Medical Coll Of Cornell Univ (PQ1) Adaptive immune and microbial mechanisms regulating Lynch syndrome penetrance RFA-CA-17-017: Research Answers to NCI's Provocative Questions
El-Serag, Hashem B Baylor College Of Medicine Prevention of Hepatocellular Carcinoma Related to Metabolic Syndrome PAR-20-077: National Cancer Institute Program Project Applications
Chung, Raymond T Massachusetts General Hospital Trial of Statins for Chemoprevention in Hepatocellular Carcinoma PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Chang, Su-Hsin Washington University Addressing racial disparities in monoclonal gammopathy of undetermined significance and progression to multiple myeloma from a prevention perspective PAR-19-279: Provocative Questions (PQs) in Multiple Myeloma Disparities Research
Chan, Andrew T Massachusetts General Hospital Effects of inflammaging on intestinal epithelial cells and aspirin chemoprevention. PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program

Pages